Key facts
- Radicle Science’s last known valuation is $20.0M (Jun 2022).
- It has raised $6.0M across 1 recorded rounds; the latest was Early Stage VC ($6.0M) in Dec 2021.
- Notable investors include Plug and Play Tech Center, Everywhere Ventures, CONNECT (San Diego), One Mind, Elevation Capital (Canada) — 14 tracked in total.
- Radicle Science has filed 2 Form Ds with the SEC, most recently Jun 2022 ($6.0M sold to 23 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Radicle Science
Funding rounds
1 roundsAbout Radicle Science
Provider of clinical research services intended to generate scientific evidence for wellness products. The company offers a digital trial platform with real-world participant data, wearable integrations and customizable study designs, enabling wellness brands and consumer health companies to validate product efficacy and support evidence-backed claims.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2020
- Employees
- 40
- Website
- radiclescience.com/
- Ownership
- Privately Held (backing)
Radicle Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Radicle Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Radicle Science in its N-PORT filings yet. We sweep new filings monthly.